Towards improved receptor targeting: anterograde transport, internalization and postendocytic trafficking of neuropeptide Y receptors
- PMID: 23449522
- DOI: 10.1515/hsz-2013-0123
Towards improved receptor targeting: anterograde transport, internalization and postendocytic trafficking of neuropeptide Y receptors
Abstract
The neuropeptide Y system is known to be involved in the regulation of many central physiological and pathophysiological processes, such as energy homeostasis, obesity, cancer, mood disorders and epilepsy. Four Y receptor subtypes have been cloned from human tissue (hY1, hY2, hY4 and hY5) that form a multiligand/multireceptor system together with their three peptidic agonists (NPY, PYY and PP). Addressing this system for medical application requires on the one hand detailed information about the receptor-ligand interaction to design subtype-selective compounds. On the other hand comprehensive knowledge about alternative receptor signaling, as well as desensitization, localization and downregulation is crucial to circumvent the development of undesired side-effects and drug resistance. By bringing such knowledge together, highly potent and long-lasting drugs with minimized side-effects can be engineered. Here, current knowledge about Y receptor export, internalization, recycling, and degradation is summarized, with a focus on the human Y receptor subtypes, and is discussed in terms of its impact on therapeutic application.
Similar articles
-
GPC receptors and not ligands decide the binding mode in neuropeptide Y multireceptor/multiligand system.Biochemistry. 2008 Jun 3;47(22):5905-14. doi: 10.1021/bi800181k. Epub 2008 May 6. Biochemistry. 2008. PMID: 18457425
-
Intracellular Trafficking of Neuropeptide Y Receptors.Prog Mol Biol Transl Sci. 2015;132:73-96. doi: 10.1016/bs.pmbts.2015.02.011. Epub 2015 Mar 25. Prog Mol Biol Transl Sci. 2015. PMID: 26055055 Review.
-
Identification of positions in the human neuropeptide Y/peptide YY receptor Y2 that contribute to pharmacological differences between receptor subtypes.Neuropeptides. 2011 Aug;45(4):293-300. doi: 10.1016/j.npep.2011.05.006. Epub 2011 Jun 22. Neuropeptides. 2011. PMID: 21696823
-
Neuropeptide Y receptors: ligand binding and trafficking suggest novel approaches in drug development.J Pept Sci. 2011 Apr;17(4):233-46. doi: 10.1002/psc.1357. Epub 2011 Feb 24. J Pept Sci. 2011. PMID: 21351324 Review.
-
Role of the C terminus in neuropeptide Y Y1 receptor desensitization and internalization.Mol Pharmacol. 2005 Mar;67(3):655-64. doi: 10.1124/mol.104.006114. Epub 2004 Dec 2. Mol Pharmacol. 2005. PMID: 15576634
Cited by
-
Neuropeptide Y and its receptors in prostate cancer: associations with cancer invasiveness and perineural spread.J Cancer Res Clin Oncol. 2023 Aug;149(9):5803-5822. doi: 10.1007/s00432-022-04540-x. Epub 2022 Dec 30. J Cancer Res Clin Oncol. 2023. PMID: 36583743 Free PMC article.
-
PET Imaging of the Neuropeptide Y System: A Systematic Review.Molecules. 2022 Jun 9;27(12):3726. doi: 10.3390/molecules27123726. Molecules. 2022. PMID: 35744852 Free PMC article. Review.
-
NanoBRET in C. elegans illuminates functional receptor interactions in real time.BMC Mol Cell Biol. 2022 Jan 31;23(1):8. doi: 10.1186/s12860-022-00405-w. BMC Mol Cell Biol. 2022. PMID: 35100990 Free PMC article.
-
Binding of Natural Peptide Ligands to the Neuropeptide Y5 Receptor.Angew Chem Int Ed Engl. 2022 Jan 26;61(5):e202108738. doi: 10.1002/anie.202108738. Epub 2021 Dec 16. Angew Chem Int Ed Engl. 2022. PMID: 34822209 Free PMC article.
-
Shuttling of Peptide-Drug Conjugates by G Protein-Coupled Receptors Is Significantly Improved by Pulsed Application.ChemMedChem. 2021 Jan 8;16(1):164-178. doi: 10.1002/cmdc.202000490. Epub 2020 Sep 3. ChemMedChem. 2021. PMID: 32700391 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
